Literature DB >> 9694049

Thrombomodulin levels in Behçet's disease with and without the factor V Leiden mutation.

A Gürgey1, A Gurler, A F Oner, L Mesci, S Kirazli.   

Abstract

The plasma levels of thrombomodulin (TM) in 34 patients with Behçet's disease and 79 healthy control subjects were studied. Eight patients had the factor V Leiden (FVL) mutation. The TM level was significantly lower in patients with the FVL mutation than in patients without the mutation and in the healthy controls (p < 0.05 and p < 0.01). However, there was no difference in overall mean plasma TM concentration between the patients without the mutation and the healthy controls.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694049     DOI: 10.1007/bf01451044

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

Review 1.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

2.  Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease.

Authors:  I C Haznedaroğlu; O Ozdemir; O Ozcebe; S V Dündar; S Kirazli
Journal:  Thromb Haemost       Date:  1996-06       Impact factor: 5.249

Review 3.  Structure and function of thrombomodulin: a natural anticoagulant.

Authors:  W A Dittman; P W Majerus
Journal:  Blood       Date:  1990-01-15       Impact factor: 22.113

4.  Factor V Leiden mutation in patients with Behçet's disease.

Authors:  A F Oner; A Gürgey; A Gürler; L Mesci
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

5.  Elevated levels of soluble thrombomodulin in plasma from children with Arg 506 to Gln mutation in the factor V gene.

Authors:  U Nowak-Göttl; H Vielhaber
Journal:  Eur J Haematol       Date:  1997-01       Impact factor: 2.997

6.  Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease.

Authors:  A Gül; U Ozbek; C Oztürk; M Inanç; M Koniçe; T Ozçelik
Journal:  Br J Rheumatol       Date:  1996-11

7.  Factor V Q 506 mutation in children with thrombosis.

Authors:  A Gurgey; L Mesci; Y Renda; L Olcay; N Kocak; G Erdem
Journal:  Am J Hematol       Date:  1996-09       Impact factor: 10.047

8.  Resistance to activated protein C as a basis for venous thrombosis.

Authors:  P J Svensson; B Dahlbäck
Journal:  N Engl J Med       Date:  1994-02-24       Impact factor: 91.245

9.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

  9 in total
  1 in total

Review 1.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.